These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3890111)

  • 21. [Immunologic phenomena and serological diagnosis of trichomonas vaginitis].
    Laudańska H; Szarmach H
    Przegl Dermatol; 1979; 66(2):191-5. PubMed ID: 384472
    [No Abstract]   [Full Text] [Related]  

  • 22. Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.
    Hernández HM; Figueredo M; Garrido N; Sánchez L; Sarracent J
    Int J Parasitol; 2005 Nov; 35(13):1333-7. PubMed ID: 16202417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis-infected women.
    Yadav M; Dubey ML; Gupta I; Malla N
    Parasite Immunol; 2007 Jul; 29(7):359-65. PubMed ID: 17576365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of mast cells in inflammation induced by Trichomonas vaginalis via crosstalk with vaginal epithelial cells.
    Han IH; Park SJ; Ahn MH; Ryu JS
    Parasite Immunol; 2012 Jan; 34(1):8-14. PubMed ID: 21981317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection of female squirrel monkeys (Saimiri sciureus) with trichomonas vaginalis as a model of trichomoniasis in women.
    Street DA; Taylor-Robinson D; Hetherington CM
    Br J Vener Dis; 1983 Aug; 59(4):249-54. PubMed ID: 6409346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases.
    Alderete JF; Newton E; Dennis C; Neale KA
    Genitourin Med; 1991 Dec; 67(6):469-74. PubMed ID: 1774051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.
    Gombosová A; Demes P; Valent M
    Genitourin Med; 1986 Apr; 62(2):107-10. PubMed ID: 3522408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactivity of Trichomonas in cervical p16INK4a immunocytochemistry is dependent on antibody, not antigen.
    Ridder R; Trunk MJ; Negri G
    Diagn Cytopathol; 2006 Jul; 34(7):512-4; author reply 515. PubMed ID: 16783782
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis.
    Romia SA; Othman TA
    J Egypt Soc Parasitol; 1991 Aug; 21(2):373-81. PubMed ID: 1875069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoglobulins in the cervico-vaginal content of clinically normal women and of women with Trichomonas, Candida or bacterial infections].
    Morelli F; Romano C; Mirra A; Galdiero F
    Nuovi Ann Ig Microbiol; 1974; 25(3):206-13. PubMed ID: 4425180
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune response to Trichomonas vaginalis. I. Genetic regulation of IgE antibody response to T. vaginalis in mice.
    Yano A; Kaji R; Kojima S; Ovary Z
    Int Arch Allergy Appl Immunol; 1982; 67(4):310-4. PubMed ID: 6802768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of latex agglutination test with conventional methods for diagnosis of trichomoniasis].
    Dymon M; Zemburowa K; Bałda R; Poteć Z
    Wiad Parazytol; 1994; 40(2):141-52. PubMed ID: 7975652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody to Trichomonas vaginalis in human cervicovaginal secretions.
    Su KE
    Infect Immun; 1982 Sep; 37(3):852-7. PubMed ID: 6982231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of trichomonal antigens by means of complement fixation].
    Iankov N; Baltova E; Ishev V; Angelova E
    Akush Ginekol (Sofiia); 1972; 11(5):450-2. PubMed ID: 4539896
    [No Abstract]   [Full Text] [Related]  

  • 35. Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test.
    Mason PR
    J Clin Pathol; 1979 Dec; 32(12):1211-5. PubMed ID: 395169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of local infection on immunoglobulin formation in the human endocervix.
    Chipperfield EJ; Evans BA
    Clin Exp Immunol; 1972 Jun; 11(2):219-33. PubMed ID: 4557181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic importance of the complement fixation test for the demonstration of Trichomonas vaginalis infections].
    Philipp G; Jankó M
    Zentralbl Gynakol; 1970 Apr; 92(15):465-8. PubMed ID: 4930753
    [No Abstract]   [Full Text] [Related]  

  • 38. [Trichomonas vaginalis in women attending gynecology clinics].
    Belek AS; Tunçkanat F
    Mikrobiyol Bul; 1993 Oct; 27(4):357-63. PubMed ID: 8264450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of Trichomonas vaginalis with direct immunofluorescence assay].
    Tian YH; Xiong CL; Guan HT; Pang XB; Jiang CF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003; 21(4):242-4. PubMed ID: 14628381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.
    Alderete JF; Suprun-Brown L; Kasmala L; Smith J; Spence M
    Infect Immun; 1985 Sep; 49(3):463-8. PubMed ID: 2411656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.